[Intracellular actions of antiplatelet drugs which affect cyclic AMP metabolism in platelets--their effects on Ca2+ mobilization and protein phosphorylation in human platelets].
Nishikawa
M
M
Saitoh
M
M
Deguchi
K
K
Shirakawa
S
S
D000527:Alprostadil / Q000031:analogs & derivatives* / Q000494:pharmacology; D001792:Blood Platelets / Q000378:metabolism*; D002118:Calcium / Q000097:blood*; D002227:Carbazoles; D005576:Colforsin / Q000494:pharmacology*; D000242:Cyclic AMP / Q000097:blood*; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D010766:Phosphorylation; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D011758:Pyrroles / Q000494:pharmacology*; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors
D002227:Carbazoles; D007211:Indoles; D010975:Platelet Aggregation Inhibitors; D011758:Pyrroles; D005576:Colforsin; D013928:Thromboxane A2; C057416:KT 5720; C025090:ONO 1206; D000242:Cyclic AMP; D011493:Protein Kinase C; D000527:Alprostadil; D002118:Calcium